Table 4.
Top 50 genes differentially expressed in tumor epithelium
| Probe set | DICS | IDC | Gene description |
| g5174662_3p_at | 5.3 | 4.0 | S100P – S100 calcium binding protein P |
| g11993936_3p_s_at | 4.5 | 3.4 | CYB561 – cytochrome b-561 |
| g7415720_3p_a_at | 4.0 | 3.0 | SCD – stearoyl-CoA desaturase (delta-9-desaturase) |
| Hs.75319.0.S3_3p_at | 3.0 | 3.8 | RRM2 – ribonucleotide reductase M2 polypeptide |
| Hs.106552.0.S3_3p_s_at | 4.2 | 2.3 | CNTNAP2 – contactin associated protein-like 2 |
| g12803628_3p_at | 3.7 | 2.6 | HIST1H1C – histone cluster 1, H1c |
| g5031780_3p_at | 4.0 | 2.3 | IFI27 – interferon, alpha-inducible protein 27 |
| Hs.180779.1.S1_3p_at | 3.1 | 3.0 | HIST1H2BD – histone cluster 1, H2bd |
| Hs.184572.0.S2_3p_at | 2.7 | 3.3 | CDC2 – cell division cycle 2, G1 to S and G2 to M |
| Hs.223025.0.S2_3p_a_at | 2.6 | 3.4 | RAB31 – RAB31, member RAS oncogene family |
| g12804874_3p_a_at | 2.8 | 3.1 | RRM2 – ribonucleotide reductase M2 polypeptide |
| Hs.239884.0.S1_3p_x_at | 3.5 | 2.4 | HIST1H2BC – histone cluster 1, H2bc |
| g7661973_3p_at | 2.7 | 3.1 | MELK – maternal embryonic leucine zipper kinase |
| g13259549_3p_at | 3.2 | 2.4 | IFI6 – interferon, alpha-inducible protein 6 |
| g4504584_3p_at | 3.5 | 2.0 | IFIT1 – interferon-induced protein with tetratricopeptide repeats 1 |
| Hs.155956.0.S1_3p_at | 2.6 | 2.8 | NAT1 – N-acetyltransferase 1 (arylamine N-acetyltransferase) |
| Hs.152677.0.S1_3p_at | 3.1 | 2.3 | DHRS2 – dehydrogenase/reductase (SDR family) member 2 |
| Hs.239884.0.S1_3p_at | 3.3 | 2.1 | HIST1H2BC – histone cluster 1, H2bc |
| g5803130_3p_a_at | 2.2 | 3.2 | RAB31 – RAB31, member RAS oncogene family |
| g13699814_3p_s_at | 2.7 | 2.7 | CYP2B6 – cytochrome P450, family 2, subfamily B, polypeptide 6 |
| g9963780_3p_a_at | 2.2 | 3.2 | RAB31 – RAB31, member RAS oncogene family |
| Hs.72472.0.A1_3p_at | 2.3 | 2.9 | - |
| g13477106_3p_s_at | 3.3 | 1.8 | CEACAM6 – carcinoembryonic antigen-related cell adhesion molecule 6 (nonspecific cross-reacting antigen) |
| Hs.133342.0.S1_3p_x_at | 2.9 | 2.2 | GPC1 – glypican 1 |
| Hs.325335.1.S1_3p_at | 2.6 | 2.5 | CAPN13 – calpain 13 |
| Hs.34853.0.S2_3p_at | -3.5 | -4.0 | ID4 – inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
| g3387766_3p_a_at | -3.9 | -3.6 | GPM6B – glycoprotein M6B |
| Hs.10587.0.S1_3p_at | -3.2 | -4.3 | DMN – desmuslin |
| Hs2.348883.1.S1_3p_s_at | -3.9 | -3.6 | FOXC1 – forkhead box C1 |
| g4758521_3p_at | -4.9 | -2.7 | SPARCL1 – SPARC-like 1 (mast9, hevin) |
| g11037715_3p_x_at | -3.9 | -3.7 | ROPN1 – ropporin, rhophilin associated protein 1 |
| g4504914_3p_at | -3.9 | -3.8 | KRT15 – keratin 15 |
| Hs.82101.0.S3_3p_at | -3.7 | -4.0 | PHLDA1 – pleckstrin homology-like domain, family A, member 1 |
| Hs.149356.0.S1_3p_at | -3.8 | -3.9 | LOC728264 – hypothetical protein LOC728264 |
| g4506856_3p_s_at | -3.3 | -4.6 | CX3CL1 – chemokine (C-X3-C motif) ligand 1 |
| g4506516_3p_at | -3.9 | -4.1 | RGS2 – regulator of G-protein signaling 2, 24 kDa |
| g7657105_3p_at | -4.2 | -4.0 | GABRP – gamma-aminobutyric acid (GABA) A receptor, pi |
| Hs.25956.0.S1_3p_at | -4.1 | -4.4 | SOSTDC1 – sclerostin domain containing 1 |
| Hs.153961.2.S2_3p_at | -4.6 | -3.9 | BOC – Boc homolog (mouse) |
| g11991655_3p_at | -4.5 | -4.2 | C2orf40 – chromosome 2 open reading frame 40 |
| Hs.288850.0.S1_3p_at | -4.1 | -4.7 | PHLDA1 – pleckstrin homology-like domain, family A, member 1 |
| g7662650_3p_at | -5.1 | -3.7 | C13orf15 – chromosome 13 open reading frame 15 |
| g4557694_3p_a_at | -4.5 | -4.5 | KIT – v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
| Hs.127428.2.S2_3p_a_at | -4.3 | -4.9 | HOXA9 – homeobox A9 |
| g6005949_3p_at | -4.4 | -4.8 | WIF1 – WNT inhibitory factor 1 |
| Hs.34853.0.S3_3p_at | -4.8 | -4.5 | ID4 – inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
| g4559274_3p_a_at | -4.1 | -5.3 | ELF5 – E74-like factor 5 (ets domain transcription factor) |
| g8400731_3p_a_at | -4.4 | -5.2 | SFRP1 – secreted frizzled-related protein 1 |
| g5032314_3p_a_at | -4.9 | -4.9 | DMD – dystrophin (muscular dystrophy, Duchenne and Becker types) |
| g6005714_3p_at | -4.7 | -5.6 | SLC6A14 – solute carrier family 6 (amino acid transporter), member 14 |
Ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC) data presented as log2(fold changes) relative to normal epithelium.